On Friday, Shares of Kinross Gold Corporation (USA) (NYSE:KGC), SUBTRACT -1.41% and closed at $4.21 in the last trading session. The last trading range of the stock ranges between $4.19 and $4.37. Kinross Gold (TSX:K.TO) (KGC) will release its financial statements and operating results for the third quarter 2016 on Wednesday, November 2, 2016, after market close. A conference call and audio webcast will then be held on November 3, 2016 at 8 a.m. ET to present the results, followed by a question-and-answer session.
Valeant Pharmaceuticals Intl Inc (NYSE:VRX), DROPPED -2.00% and closed at $24.55 in the last trading session. The last trading range of the stock ranges between $24.53 and $25.54. The company’s Market capitalization is $8.20 Billion with the total Outstanding Shares of 341.19 Million. Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM) declares its (unaudited) financial report for the eight months ended 31 August 2016. These financial statements are being published to provide all shareholders and shareholders with the most current financial information in order to facilitate a full understanding of the implications of the Company’s recently declared deal to acquire the commercialization rights to RUCONEST® in North America from its partner Valeant and the related projected financing activity.
These results do not replace the quarterly report for the first nine months of 2016, which is because of be published on 27 October 2016.
- Sales of RUCONEST® for the period to 31 August were up 48% overall contrast to the six months to 30 June 2016, so that sales in the two months of July and August alone were higher than the whole of the first quarter this year.
- Sales in the US to 31 August up by about 28% contrast to the same period last year, and up 43% contrast to the first half year of 2016.
- Gross Profit raised by 24% relative to the same period last year, and up 42% contrast to the first half year of 2016.